Affinity purification of cross-ß fibrils using immobilized thioflavin
使用固定化硫代黄素对交叉原纤维进行亲和纯化
基本信息
- 批准号:10646061
- 负责人:
- 金额:$ 18.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalActinsAffinityAffinity ChromatographyAlzheimer&aposs DiseaseAmericanAmino Acid SequenceAmyloidAmyloid ProteinsAmyloid beta-ProteinAreaAutopsyBindingBiological AssayBrainBuffersCell Culture TechniquesCell modelCentrifugationCerebrospinal FluidCharacteristicsCollagenColumn ChromatographyCongo RedCryoelectron MicroscopyDementiaDepositionDetergentsDevelopmentDiagnostic ProcedureDiagnostic ReagentDiseaseDisease ProgressionDrug DesignDyesEconomic BurdenEconomicsEtiologyExclusionExhibitsFeasibility StudiesFerritinFilamentFluorescenceFluorescent ProbesFreezingHourImageImmobilizationIn VitroIndividualKineticsLengthLife ExpectancyMass Spectrum AnalysisMethodsModernizationMolecular ConformationMovement DisordersNatureNeurodegenerative DisordersNuclear Magnetic ResonanceOxidesPatientsPeptidesPharmaceutical PreparationsPost-Translational Protein ProcessingPreparationPrionsProceduresPropertyProtein AnalysisProteinsRecombinant ProteinsRecombinantsReportingResearch PersonnelResolutionSamplingSenile PlaquesSeveritiesSocietiesSourceSpecificitySurfaceTherapeuticThioflavin STimeTissue SampleUltracentrifugationVesicleWidthWorkX-Ray Crystallographyalpha synucleinamyloid formationamyloid structurebrain tissuecostdensitydesignexperimental studyfeasibility testinggraphenehistological specimensimprovedin vivointerestmagnetic beadsmetermonolayermotor disorderneuropathologypreservationpreventprotein aggregationprotein foldingprotein purificationprotein structurereconstructionsocioeconomicsstructural biologytau Proteinstechnology developmenttissue degenerationtool
项目摘要
Project Summary
Neurodegenerative diseases such as Alzheimer’s disease cause a significant socioeconomic burden. These
diseases manifest as protein plaques in the brain tissues. As of today, there are no available drugs to treat
or prevent these diseases. For rational drug design, it is essential to understand the atomic details of the
proteins involved in these plaques. To achieve this, researchers utilize structural biology methods such as
electron cryomicroscopy (cryoEM), nuclear magnetic resonance, and X-ray crystallography.
Neuropathologists isolate these plaques from post-mortem patient brain tissues and assess the disease for
the presence of plaques. Then the samples are subjected to structural studies. Since 2017, a significant
number of atomic structures of the protein molecules involved in the plaques have been reported. However,
isolation of proteins from tissue samples is a bottleneck due to low yield, differences in the protein structures,
and the presence of contaminants. The proteins in the plaques have a distinct arrangement in that they form
a β-strand conformation and stack on top of each other along a helical axis. This arrangement gives rise to
a unique property – they bind to molecules such as thioflavin and exhibit characteristic fluorescence emission.
Such a property enables researchers to know the presence of protein plaques and quantify them in cellular
models. Here, we propose to utilize the specificity of thioflavin to protein filaments of neuropathological
plaques as a new method of plaque purification. The method combines the specificity of thioflavin to the
protein filaments and affinity-based purification methods that are widely used to purify proteins. We propose
that our method would enable researchers to extract and isolate protein filaments from brain tissues with
much improved yields, fewer contaminants, and shorter processing times.
项目概要
阿尔茨海默病等神经退行性疾病造成了巨大的社会经济负担。这些
疾病表现为脑组织中的蛋白质斑块。截至目前,尚无可用药物可以治疗
或预防这些疾病。对于合理的药物设计,了解药物的原子细节至关重要
参与这些斑块的蛋白质。为了实现这一目标,研究人员利用结构生物学方法,例如
电子冷冻显微镜 (cryoEM)、核磁共振和 X 射线晶体学。
神经病理学家从死后患者脑组织中分离出这些斑块,并对疾病进行评估
斑块的存在。然后对样品进行结构研究。自 2017 年以来,显着
斑块中涉及的蛋白质分子的原子结构的数量已被报道。然而,
由于产量低、蛋白质结构差异,从组织样品中分离蛋白质是一个瓶颈,
以及污染物的存在。斑块中的蛋白质具有独特的排列,它们形成
β-链构象并沿螺旋轴彼此堆叠。这种安排导致
一种独特的特性——它们与硫代黄素等分子结合并表现出特征性的荧光发射。
这种特性使研究人员能够了解蛋白质斑块的存在并在细胞中对其进行量化
模型。在这里,我们建议利用硫代黄素对神经病理学蛋白丝的特异性
噬菌斑作为一种新的噬菌斑净化方法。该方法结合了硫代黄素对
蛋白质丝和广泛用于纯化蛋白质的基于亲和力的纯化方法。我们建议
我们的方法将使研究人员能够从脑组织中提取和分离蛋白质丝
大大提高产量、减少污染物并缩短加工时间。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Wen Jiang其他文献
Wen Jiang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Wen Jiang', 18)}}的其他基金
Engineering In Vivo Chimeric Antigen Receptor Macrophages (CARMs) using mRNA-exosomes for Cancer Immunotherapy
使用 mRNA-外泌体工程体内嵌合抗原受体巨噬细胞 (CARM) 用于癌症免疫治疗
- 批准号:
10740743 - 财政年份:2023
- 资助金额:
$ 18.43万 - 项目类别:
A Phagocytosis Modulating Nanomedicine for Targeted Breast Cancer Immunotherapy
用于靶向乳腺癌免疫治疗的吞噬调节纳米药物
- 批准号:
10381905 - 财政年份:2021
- 资助金额:
$ 18.43万 - 项目类别:
Therapeutic targeting of multiple glioblastoma phagocytosis checkpoints using a novel bispecific antibody
使用新型双特异性抗体靶向治疗多个胶质母细胞瘤吞噬检查点
- 批准号:
10428596 - 财政年份:2021
- 资助金额:
$ 18.43万 - 项目类别:
Therapeutic targeting of multiple glioblastoma phagocytosis checkpoints using a novel bispecific antibody
使用新型双特异性抗体靶向治疗多个胶质母细胞瘤吞噬检查点
- 批准号:
10212046 - 财政年份:2021
- 资助金额:
$ 18.43万 - 项目类别:
Therapeutic targeting of multiple glioblastoma phagocytosis checkpoints using a novel bispecific antibody
使用新型双特异性抗体靶向治疗多个胶质母细胞瘤吞噬检查点
- 批准号:
10609925 - 财政年份:2021
- 资助金额:
$ 18.43万 - 项目类别:
Renal Cell Carcinoma Surveillance by Immuno-Lipoplex Nanoparticle Platform
通过免疫脂质体纳米颗粒平台监测肾细胞癌
- 批准号:
10544876 - 财政年份:2020
- 资助金额:
$ 18.43万 - 项目类别:
Renal Cell Carcinoma Surveillance by Immuno-Lipoplex Nanoparticle Platform
通过免疫脂质体纳米颗粒平台监测肾细胞癌
- 批准号:
10044277 - 财政年份:2020
- 资助金额:
$ 18.43万 - 项目类别:
A Phagocytosis Modulating Nanomedicine for Targeted Breast Cancer Immunotherapy
用于靶向乳腺癌免疫治疗的吞噬调节纳米药物
- 批准号:
9805697 - 财政年份:2019
- 资助金额:
$ 18.43万 - 项目类别:
HBGA receptors in host cell entry and infection of norovirus
HBGA受体在诺如病毒进入宿主细胞和感染中的作用
- 批准号:
9182813 - 财政年份:2014
- 资助金额:
$ 18.43万 - 项目类别:
HBGA receptors in host cell entry and infection of norovirus
HBGA受体在诺如病毒进入宿主细胞和感染中的作用
- 批准号:
8967560 - 财政年份:2014
- 资助金额:
$ 18.43万 - 项目类别:
相似海外基金
A novel motility system driven by two classes of bacterial actins MreB
由两类细菌肌动蛋白 MreB 驱动的新型运动系统
- 批准号:
22KJ2613 - 财政年份:2023
- 资助金额:
$ 18.43万 - 项目类别:
Grant-in-Aid for JSPS Fellows
The structural basis of plasmid segregation by bacterial actins
细菌肌动蛋白分离质粒的结构基础
- 批准号:
342887 - 财政年份:2016
- 资助金额:
$ 18.43万 - 项目类别:
Operating Grants
The structural basis for plasmid segregation by bacterial actins
细菌肌动蛋白分离质粒的结构基础
- 批准号:
278338 - 财政年份:2013
- 资助金额:
$ 18.43万 - 项目类别:
Operating Grants
Cytoplasmic Actins in Maintenance of Muscle Mitochondria
细胞质肌动蛋白在维持肌肉线粒体中的作用
- 批准号:
8505938 - 财政年份:2012
- 资助金额:
$ 18.43万 - 项目类别:
Differential Expression of the Diverse Plant Actins
多种植物肌动蛋白的差异表达
- 批准号:
7931495 - 财政年份:2009
- 资助金额:
$ 18.43万 - 项目类别:
Studies on how actins and microtubules are coordinated and its relevancy.
研究肌动蛋白和微管如何协调及其相关性。
- 批准号:
19390048 - 财政年份:2007
- 资助金额:
$ 18.43万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Interaction of myosin with monomeric actins
肌球蛋白与单体肌动蛋白的相互作用
- 批准号:
5311554 - 财政年份:2001
- 资助金额:
$ 18.43万 - 项目类别:
Priority Programmes
STRUCTURE/INTERACTIONS OF ACTINS AND ACTIN-BINDING PROTEIN
肌动蛋白和肌动蛋白结合蛋白的结构/相互作用
- 批准号:
6316669 - 财政年份:2000
- 资助金额:
$ 18.43万 - 项目类别:














{{item.name}}会员




